Aerie Pharmaceuticals reported $47K in Ordinary Share Capital for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Adamas Pharmaceuticals ADMS:US 50K 0
Aerie Pharmaceuticals AERI:US $ 0.05M 0M
Alimera Sciences ALIM:US $ 0.07M 0M
Amarin AMRN:US $ 293.14M 0.36M
Bluebird Bio BLUE:US $ 0.7M 0.02M
Cara Therapeutics CARA:US $ 50K 0
Coherus Biosciences CHRS:US $ 0.01M 0M
Endo International Ordinary Shares ENDP:US $ 0.07M 0M
Flexion Therapeutics FLXN:US $ 50K 0
Gw Pharmaceuticals GWPH:US $ 0.58M 0.01M
Horizon Pharma HZNP:US $ 0.02M 0M
Insmed INSM:US $ 1.18M 32K
Mirati Therapeutics MRTX:US $ 0.05M 0M
Novartis NOVN:VX SF 901M 12M
Pacira Pharmaceuticals PCRX:US $ 0.04M 0M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M
Revance Therapeutics RVNC:US $ 0.07M 0M
Supernus Pharmaceuticals SUPN:US $ 0.05M 0M
Teva Pharmaceutical Industries TEVA:US $ 57M 0M
Valeant Pharmaceuticals VRX:CN $ 10312M 12M
Zoetis ZTS:US $ 5M 0M